Qin Bolin, Nagasaki Masaru, Ren Ming, Bajotto Gustavo, Oshida Yoshiharu, Sato Yuzo
Department of Sports Medicine, Graduate School of Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464 -8601, Japan.
Life Sci. 2003 Oct 10;73(21):2687-701. doi: 10.1016/s0024-3205(03)00640-4.
This study investigated the effects of the traditional herbal medicine, Keishi-ka-jutsubu-to (KJT) on insulin action in vivo and insulin signaling in skeletal muscle in STZ-induced diabetes. Rats were divided into single and 7-days oral administration groups. Euglycemic clamp (insulin infusion rates: 3 and 30 mU/kg/min) was used in awaked rats and the insulin signaling in skeletal muscle was evaluated. At low-dose insulin infusion, the decreased metabolic clearance rates of glucose (MCR) in diabetic rats were improved by a single and 7-days administration of KJT (800 mg/kg BW, p.o.; acute effect: 6.7 +/- 0.6 vs. 12.3 +/- 1.2, and 7-days effect: 6.3 +/- 0.5 vs. 13.9 +/- 1.0 ml/kg/min, P<0.001, respectively). During high-dose insulin infusion, the MCR was increased in 7-days KJT treated diabetes compared with saline diabetes, but, these changes were not observed after a single KJT treatment. About 90% of the increasing effect in MCR induced by the 7-days KJT treatment was blocked by L-NMMA. However, no further additive effects were seen in KJT + SNP treatment. IRbeta protein increase and decreased IRS-1 protein expression in diabetes were significantly improved by KJT treatment. KJT had no effect on the GLUT4 protein content. The increased tyrosine phosphorylation level of IRbeta, IRS-1, and IRS-1 associated with PI 3-kinase were significantly inhibited in KJT treated diabetes. The present study suggests that the improvement of impaired insulin action in STZ-diabetes by administration of KJT may be due, at least in part, to enhanced insulin signaling, which may be involved with production of nitric oxide (NO).
本研究调查了传统草药桂枝加术附汤(KJT)对链脲佐菌素诱导的糖尿病大鼠体内胰岛素作用及骨骼肌胰岛素信号传导的影响。大鼠被分为单次给药组和连续7天给药组。对清醒大鼠采用正常血糖钳夹技术(胰岛素输注速率:3和30 mU/kg/min),并评估骨骼肌中的胰岛素信号传导。在低剂量胰岛素输注时,单次及连续7天给予KJT(800 mg/kg体重,口服)可改善糖尿病大鼠降低的葡萄糖代谢清除率(MCR)(急性效应:6.7±0.6对12.3±1.2,7天效应:6.3±0.5对13.9±1.0 ml/kg/min,P均<0.001)。在高剂量胰岛素输注期间,与生理盐水处理的糖尿病大鼠相比,连续7天给予KJT治疗的糖尿病大鼠MCR增加,但单次给予KJT治疗后未观察到这些变化。连续7天给予KJT治疗诱导的MCR增加效应中约90%被L-NMMA阻断。然而,KJT + SNP联合处理未见进一步的相加效应。KJT治疗可显著改善糖尿病时IRbeta蛋白增加及IRS-1蛋白表达降低的情况。KJT对GLUT4蛋白含量无影响。KJT处理的糖尿病大鼠中,IRbetabeta、IRS-1以及与PI 3-激酶相关的IRS-1酪氨酸磷酸化水平增加均受到显著抑制。本研究提示,给予KJT改善链脲佐菌素诱导的糖尿病大鼠受损的胰岛素作用,可能至少部分归因于胰岛素信号传导增强,这可能与一氧化氮(NO)的产生有关。